Fe(II)-IAFP2 磁共振静默可激活探针实现炎症相关纤维化的快速检测
Magnetic Resonance Silent Activatable Probe with Massive Signal Amplification for Rapid Detection of Inflammation-Associated Fibrogenesis
一种名为 Fe(II)-IAFP2 的磁共振探针在小鼠肾与肝纤维化模型中,静脉注射后数分钟内即产生与疾病相关的 MR 对比信号。该探针在 Fe(II) 状态呈 MR 静默,在炎症纤维化微环境中被氧化为 Fe(III) 后激活增强,并借助醛介导的可逆结合于重塑细胞外基质而进一步放大弛豫率、滞留于损伤部位。
- 背景
- 分子影像常受困于难以区分特异性分子信号与探针分布带来的非特异信号,在肾脏、肝脏这类代谢活跃器官尤为明显,因此多数分子影像只能依靠延迟成像获得特异性,限制了临床通量和快速评估。
- 做法
- 作者构建了铁(II)配合物探针Fe(II)-IAFP2,将三种提升弛豫率的驱动因素结合:探针在Fe(II)态为MR静默,在炎症、纤维化微环境中快速氧化为Fe(III)后激活MR增强,同时通过可逆的醛介导结合于重塑的细胞外基质,进一步放大弛豫率并促进在损伤部位滞留。
- 结论
- 在肾与肝纤维化小鼠模型中,静脉给药后数分钟内即可产生与疾病相关的MR对比信号,说明激活与滞留的双重机制能在给药后短时间内形成信号,而不必依赖延迟成像。
- 意义
- 该工作给出了一种基于病理活性的快速分子MR成像策略,把特异性从探针分布中解耦出来;目前证据来自小鼠纤维化模型,向临床场景的适用性仍需进一步验证。
原文摘要
出版方登记 · CrossrefBiomarker-specific molecular imaging is vital in precision medicine. However, a fundamental challenge of most molecular imaging methods is the difficulty of distinguishing specific molecular signal from nonspecific signal arising from the distribution of the molecular probe. This is even more pronounced in metabolically active organs such as the kidney and liver where the probe may concentrate prior to elimination. As a result, almost all molecular imaging relies on delayed imaging to achieve specificity, but this constrains clinical throughput and impedes rapid assessment of the diseased organ. Here, we report a magnetic resonance (MR) probe, Fe(II)-IAFP2, which combines 3 drivers of relaxivity enhancement to decouple disease specificity from probe distribution. Fe(II)-IAFP2 is MR-silent in its Fe(II) state, producing negligible MR signal even at high concentrations. In inflammatory, fibrogenic microenvironments common to many diseases, rapid oxidation to Fe(III) activates MR enhancement, while reversible aldehyde-mediated binding to remodeled extracellular matrix further amplifies relaxivity and promotes retention at the site of tissue injury. This dual activation–retention mechanism enables robust signal generation within minutes of administration. In mouse models of renal and liver fibrogenesis, Fe(II)-IAFP2 generated disease-associated MR contrast within minutes after intravenous administration. Together, this work demonstrates an effective strategy for rapid, activity-based molecular MR imaging through the combination of pathological activation and complementary tissue retention.
页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文
本页是 AI 精读,不转载论文原文;完整论文(含方法、图表与参考文献)见原文
来源:Journal of the American Chemical Society · doi.org